This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Norway? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Slovakia. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Slovakia? Read Post »
ORILISSA (elagolix sodium) Abbvie Patent: 7,176,211 Expiration: Jul 6, 2024 See More … For more information on how DrugPatentWatch can […]
Source
Drug Patent Expirations for the Week of June 30, 2024 Read Post »
Annual Drug Patent Expirations for NORLIQVA Norliqva is a drug marketed by Cmp Dev Llc and is included in one […]
Source
Annual Drug Patent Expirations for LIQREV Liqrev is a drug marketed by Cmp Dev Llc and is included in one […]
Source
Annual Drug Patent Expirations for KRAZATI Krazati is a drug marketed by Mirati Theraps and is included in one NDA. […]
Source
Annual Drug Patent Expirations for SPINRAZA Spinraza is a drug marketed by Biogen Idec and is included in one NDA. […]
Source
Annual Drug Patent Expirations for MOTPOLY+XR Motpoly Xr is a drug marketed by Aucta and is included in one NDA. […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »